Download PDF
Semin intervent Radiol 2010; 27(4): 391-399
DOI: 10.1055/s-0030-1267848
© Thieme Medical Publishers

Pharmacology of Sclerotherapy

Giustino Albanese1 , Kimi L. Kondo1
  • 1Department of Radiology, University of Colorado Denver School of Medicine, Aurora, Colorado
Further Information

Publication History

Publication Date:
19 November 2010 (online)

Also available at
    Permissions and Reprints

ABSTRACT

Sclerotherapy is the therapeutic use of sclerosants in the controlled destruction of undesired target tissues. Sclerosants have been used in vascular and nonvascular settings, both as primary and adjunctive therapy. Effective sclerotherapy requires a conceptual understanding of key questions about the process being treated, including the method of delivery, the presence of flow, and the required contact time to initiate sclerosis. However, beyond technique and delivery, practical and safe application of sclerotherapy requires an understanding of the uses, limitations, dosing, and side effects of sclerosants used during interventional radiology procedures. Agents discussed here include detergents and surfactants [ethanol, Sotradecol® (Bioniche Pharma, Pointe Claire, Quebec and Angiodynamics, Latham, NY), ethanolamine oleate], hypertonics (saline, glucose), and a review of several other types that are used less frequently.

KEYWORDS

Sclerotherapy - ethanol - Sotradecol® - hypertonic solutions - ethanolamine oleate - sclerosants

REFERENCES

  • 1 Sasaki M, Tadokoro S, Kimura S, Mori M, Kosuda S, Tachibana M. Two cases of renal arteriovenous fistula treated by transcatheter embolization with absolute ethanol.  Hinyokika Kiyo. 1984;  30(3) 295-298
    PubMedGoogle Scholar
  • 2 Yakes W F, Pevsner P, Reed M, Donohue H J, Ghaed N. Serial embolizations of an extremity arteriovenous malformation with alcohol via direct percutaneous puncture.  AJR Am J Roentgenol. 1986;  146(5) 1038-1040
    CrossrefPubMedGoogle Scholar
  • 3 Becker G H, Holden R W, Heun Y Y, Klatte E C. Ablation with absolute alcohol. In: Castaneda-Zuniga WR, Tadavarthy SM Interventional Radiology. Baltimore; Williams and Wilkins 1992: 135-152
    Google Scholar
  • 4 Ellman B A, Green C E, Eigenbrodt E, Garriott J C, Curry T S. Renal infarction with absolute ethanol.  Invest Radiol. 1980;  15(4) 318-322
    CrossrefPubMedGoogle Scholar
  • 5 Do Y S, Yakes W F, Shin S W et al.. Ethanol embolization of arteriovenous malformations: interim results.  Radiology. 2005;  235(2) 674-682
    CrossrefPubMedGoogle Scholar
  • 6 Mourao G S, Hodes J E, Gobin Y P, Casasco A, Aymard A, Merland J J. Curative treatment of scalp arteriovenous fistulas by direct puncture and embolization with absolute alcohol. Report of three cases.  J Neurosurg. 1991;  75(4) 634-637
    CrossrefPubMedGoogle Scholar
  • 7 Hyodoh H, Hori M, Akiba H, Tamakawa M, Hyodoh K, Hareyama M. Peripheral vascular malformations: imaging, treatment approaches, and therapeutic issues.  Radiographics. 2005;  25(Suppl 1) S159-S171
    CrossrefPubMedGoogle Scholar
  • 8 Ellman B A, Parkhill B J, Marcus P B, Curry T S, Peters P C. Renal ablation with absolute ethanol. Mechanism of action.  Invest Radiol. 1984;  19(5) 416-423
    CrossrefPubMedGoogle Scholar
  • 9 Rabe F E, Yune H Y, Richmond B D, Klatte E C. Renal tumor infarction with absolute ethanol.  AJR Am. J Roentgenol. 1982;  139 343-345
    PubMedGoogle Scholar
  • 10 Dubois J, Garel L, Gordon Culham J A. Pediatric interventional angiography. In: Baum S, Pentecost MJ Abrams' Angiography Interventional Radiology. 2nd ed. Philadelphia; Lippincott Williams and Wilkins 2006: 1047-1068
    Google Scholar
  • 11 Katz J M, Gobin Y P, Riina H A. Techniques and devices in interventional neuroradiology. In: Hurst RW, Rosenwasser RH Interventional Neuroradiology. New York; Informa 2008: 161-182
    Google Scholar
  • 12 American Society of Gastroenterology . Technology Status Evaluation Report: Sclerosing agents for use in GI endoscopy.  Gastrointest Endosc. 2007;  66(1) 1-6
    CrossrefPubMedGoogle Scholar
  • 13 Moller J E, Helweg-Larsen J, Jacobsen E. Histopathological lesions in the sciatic nerve of the rat following perineural application of phenol and alcohol solutions.  Dan Med Bull. 1969;  16(4) 116-119
    PubMedGoogle Scholar
  • 14 Rumsby M G, Finean J B. The action of organic solvents on the myelin sheath of peripheral nerve tissue. 3. Chlorinated hydrocarbons.  J Neurochem. 1966;  13(12) 1513-1515
    CrossrefPubMedGoogle Scholar
  • 15 Politis M J, Schaumburg H H, Spencer P S. Neurotoxicity of selected chemicals. In: Spencer PS, Schaumburg HH Experimental and chemical neurotoxicity. Baltimore; Williams and Wilkins 1980: 613-630
    Google Scholar
  • 16 Simonetti G, Profili S, Sergiacomi G L, Meloni G B, Orlacchio A. Percutaneous treatment of hepatic cysts by aspiration and sclerotherapy.  Cardiovasc Intervent Radiol. 1993;  16(2) 81-84
    CrossrefPubMedGoogle Scholar
  • 17 Darcy M. Renal cysts and urinomas. In: Baum S, Pentecost MJ Abrams' Angiography Interventional Radiology. 2nd ed. Philadelphia; Lippincott Williams and Wilkins 2006: 764-776
    Google Scholar
  • 18 Yakes W S, Parker S H. Diagnosis and management of vascular anomalies. In: Castaneda-Zuniga WR, Tadavarthy SM Interventional Radiology. Baltimore; Williams and Wilkins 1992: 152-189
    Google Scholar
  • 19 Phan P, Burton A W. Interventional pain procedures for cancer pain. In: Baum S, Pentecost MJ Abrams' Angiography Interventional Radiology. 2nd ed. Philadelphia; Lippincott Williams and Wilkins 2006: 31-55
    Google Scholar
  • 20 Mason K P, Neufeld E J, Karian V E, Zurakowski D, Koka B V, Burrows P E. Coagulation abnormalities in pediatric and adult patients after sclerotherapy or embolization of vascular anomalies.  AJR Am J Roentgenol. 2001;  177(6) 1359-1363
    PubMedGoogle Scholar
  • 21 Dietzek C L. Sclerotherapy: introduction to solutions and techniques.  Perspect Vasc Surg Endovasc Ther. 2007;  19(3) 317-324
    CrossrefPubMedGoogle Scholar
  • 22 Ramírez-Amador V, Esquivel-Pedraza L, Lozada-Nur F et al.. Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi's sarcoma. A double blind, randomized clinical trial.  Oral Oncol. 2002;  38(5) 460-467
    CrossrefPubMedGoogle Scholar
  • 23 Ajekigbe L, Stothard J. The effectiveness of sodium tetradecyl sodium in the treatment of wrist ganglia.  Can J Plast Surg. 2006 Spring;  14(1) 28-30
    PubMedGoogle Scholar
  • 24 Cho K J, Brady T M, Anver M R. Renal artery occlusion and infarction with Sotradecol.  Invest Radiol. 1983;  18(1) 68-73
    CrossrefPubMedGoogle Scholar
  • 25 Becker G J, Kopecky K K. Can the newer interventional procedures replace cholecystectomy for cholecystolithiasis? The potential role of percutaneous cystic duct ablation.  Radiology. 1988;  167(1) 275-279
    PubMedGoogle Scholar
  • 26 Kinnison M L, Kadir S, Strandberg J D, Anderson J H, White Jr R I. Percutaneous spermatic vein occlusion: evaluation of sclerosing agents in experimental animals.  Radiology. 1986;  161(2) 299-301
    PubMedGoogle Scholar
  • 27 Girard M J, Saini S, Mueller P R et al.. Percutaneous chemical gallbladder sclerosis after laser-induced cystic duct obliteration: results in an experimental model.  AJR Am J Roentgenol. 1992;  159(5) 997-999
    PubMedGoogle Scholar
  • 28 Becker C D, Quenville N F, Burhenne H J. Gallbladder ablation through radiologic intervention: an experimental alternative to cholecystectomy.  Radiology. 1989;  171(1) 235-240
    PubMedGoogle Scholar
  • 29 Gomes A S. Embolization therapy of congenital arteriovenous malformations: use of alternate approaches.  Radiology. 1994;  190(1) 191-198
    PubMedGoogle Scholar
  • 30 O'Donovan J C, Donaldson J S, Morello F P, Pensler J M, Vogelzang R L, Bauer B. Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate.  AJR Am J Roentgenol. 1997;  169(3) 723-729
    CrossrefPubMedGoogle Scholar
  • 31 Gandini R, Konda D, Reale C A et al.. Male varicocele: transcatheter foam sclerotherapy with sodium tetradecyl sulfate—outcome in 244 patients.  Radiology. 2008;  246(2) 612-618
    CrossrefPubMedGoogle Scholar
  • 32 Gandini R, Chiocchi M, Konda D, Pampana E, Fabiano S, Simonetti G. Transcatheter foam sclerotherapy of symptomatic female varicocele with sodium-tetradecyl-sulfate foam.  Cardiovasc Intervent Radiol. 2008;  31(4) 778-784 , Such
    CrossrefPubMedGoogle Scholar
  • 33 Tan K T, Kirby J, Rajan D K, Hayeems E, Beecroft J R, Simons M E. Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience.  J Vasc Interv Radiol. 2007;  18(3) 343-351
    CrossrefPubMedGoogle Scholar
  • 34 Pereiras R, Viamonte Jr M, Russell E, LePage J, White P, Hutson D. New techniques for interruption of gastroesophageal venous blood flow.  Radiology. 1977;  124(2) 313-323
    PubMedGoogle Scholar
  • 35 Ellman B A, Curry III T S, Glotzbach R E, Simpson P R. Systemic embolization as a complication of transhepatic venography.  Radiology. 1981;  141(1) 67-71
    PubMedGoogle Scholar
  • 36 Feldman L, Greenfield A J, Waltman A C et al.. Transcatheter vessel occlusion: angiographic results versus clinical success.  Radiology. 1983;  147(1) 1-5
    PubMedGoogle Scholar
  • 37 Becker C D, Fache J S, Malone D E, Stoller J L, Burhenne H J. Ablation of the cystic duct and gallbladder: clinical observations.  Radiology. 1990;  176(3) 687-690
    PubMedGoogle Scholar
  • 38 Becker G J, Kopecky K K. Can the newer interventional procedures replace cholecystectomy for cholecystolithiasis? The potential role of percutaneous cystic duct ablation.  Radiology. 1988;  167(1) 275-279
    PubMedGoogle Scholar
  • 39 Girard M J, Saini S, Mueller P R et al.. Percutaneous chemical gallbladder sclerosis after laser-induced cystic duct obliteration: results in an experimental model.  AJR Am J Roentgenol. 1992;  159(5) 997-999
    PubMedGoogle Scholar
  • 40 Martin E C, Getrajdman G I. Does the gallbladder have a future?.  Radiology. 1989;  170(3 Pt 2) 969-973
    PubMedGoogle Scholar
  • 41 Bergan J, Pascarella L, Mekenas L. Venous disorders: treatment with sclerosant foam.  J Cardiovasc Surg (Torino). 2006;  47(1) 9-18
    PubMedGoogle Scholar
  • 42 Tisi P V, Beverley C, Rees A. Injection sclerotherapy for varicose veins. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD001732. DOI:10.1002/14651858. CD001732.pub2
    Google Scholar
  • 43 Coleridge Smith P. Saphenous ablation: sclerosant or sclerofoam?.  Semin Vasc Surg. 2005;  18(1) 19-24
    CrossrefPubMedGoogle Scholar
  • 44 Pope A J, Ormiston M C, Bogod D G. Sclerotherapy in the treatment of recurrent lymphocele.  Postgrad Med J. 1982;  58(683) 573-574
    CrossrefPubMedGoogle Scholar
  • 45 Mason K P, Neufeld E J, Karian V E, Zurakowski D, Koka B V, Burrows P E. Coagulation abnormalities in pediatric and adult patients after sclerotherapy or embolization of vascular anomalies.  AJR Am J Roentgenol. 2001;  177(6) 1359-1363
    PubMedGoogle Scholar
  • 46 QOL Medical. Corporate Web site. http://Available at: www.ethamolin.net Accessed January 10, 2010
    Google Scholar
  • 47 Masaki M, Obara K, Suzuki S et al.. The destructive effects of sclerosant ethanolamine oleate on mammalian vessel endothelium.  Gastroenterol Jpn. 1990;  25(2) 230-235
    PubMedGoogle Scholar
  • 48 Kiyosue H, Mori H, Matsumoto S, Yamada Y, Hori Y, Okino Y. Transcatheter obliteration of gastric varices: Part 2. Strategy and techniques based on hemodynamic features.  Radiographics. 2003;  23(4) 921-937 discussion 937
    CrossrefPubMedGoogle Scholar
  • 49 Coldwell D M. Invited Commentary.  Radiographics. 2003;  23 937
    CrossrefPubMedGoogle Scholar
  • 50 Beppu T, Iwatsuki M, Okabe H et al.. A new approach to percutaneous transhepatic portal embolization using ethanolamine oleate iopamidol.  J Gastroenterol. 2010;  45(2) 211-217
    CrossrefPubMedGoogle Scholar
  • 51 Kaji N, Kurita M, Ozaki M et al.. Experience of sclerotherapy and embolosclerotherapy using ethanolamine oleate for vascular malformations of the head and neck.  Scand J Plast Reconstr Surg Hand Surg. 2009;  43(3) 126-136
    CrossrefPubMedGoogle Scholar
  • 52 Hyodoh H, Akiba H, Hyodoh K, Ezoe K, Yotsuyanagi T, Hareyama M. Effects of blood flow control on clinical outcomes after ethanolamine oleate sclerotherapy for vascular malformations.  Jpn J Radiol. 2009;  27(8) 297-302
    CrossrefPubMedGoogle Scholar
  • 53 Hyodoh H, Hori M, Akiba H, Tamakawa M, Hyodoh K, Hareyama M. Peripheral vascular malformations: imaging, treatment approaches, and therapeutic issues.  Radiographics. 2005;  25(Suppl 1) S159-S171
    CrossrefPubMedGoogle Scholar
  • 54 Kayama H, Inamori M, Togawa J et al.. Pleural effusions following endoscopic injection sclerotherapy for cirrhotic patients with esophageal varices.  Hepatogastroenterology. 2006;  53(69) 376-380
    PubMedGoogle Scholar
  • 55 Kilicoglu B, Kismet K, Kilicoglu S S et al.. Effects of honey as a scolicidal agent on the hepatobiliary system.  World J Gastroenterol. 2008;  14(13) 2085-2088
    CrossrefPubMedGoogle Scholar
  • 56 Goldman M P. A comparison of sclerosing agents. Clinical and histologic effects of intravascular sodium morrhuate, ethanolamine oleate, hypertonic saline (11.7%), and sclerodex in the dorsal rabbit ear vein.  J Dermatol Surg Oncol. 1991;  17(4) 354-362
    PubMedGoogle Scholar
  • 57 Lu Y Q, Huang W D, Cai X J, Gu L H, Mou H Z. Hypertonic saline resuscitation reduces apoptosis of intestinal mucosa in a rat model of hemorrhagic shock.  J Zhejiang Univ Sci B. 2008;  9(11) 879-884
    CrossrefPubMedGoogle Scholar
  • 58 Mactier R A. The spectrum of peritoneal fibrosing syndromes in peritoneal dialysis.  Adv Perit Dial. 2000;  16 223-228
    PubMedGoogle Scholar
  • 59 Soria M, Arrieta J, Ugarte I, Moina I, Guerra M, Escanero J. [Intracellular pH changes induced by sclerosing agents in peritoneal fibroblasts].  Nefrologia. 2004;  24(2) 158-166
    PubMedGoogle Scholar
  • 60 van Westrhenen R, Vlijm A, Hiralall J K, Krediet R T. Experimental study on long-term exposure to a biocompatible, hypertonic, pyruvate-buffered dialysis solution.  Perit Dial Int. 2008;  28(Suppl 5) S43-S47
    PubMedGoogle Scholar
  • 61 Akhan O, Gumus B, Akinci D, Karcaaltincaba M, Ozmen M. Diagnosis and percutaneous treatment of soft-tissue hydatid cysts.  Cardiovasc Intervent Radiol. 2007;  30(3) 419-425
    CrossrefPubMedGoogle Scholar
  • 62 Min T. Interventional radiology of venous insufficiency. In: Baum S, Pentecost MJ Abrams' Angiography Interventional Radiology. 2nd ed. Philadelphia; Lippincott Williams and Wilkins 2006: 1099-1109
    Google Scholar
  • 63 Sadick N S. Hyperosmolar versus detergent sclerosing agents in sclerotherapy. Effect on distal vessel obliteration.  J Dermatol Surg Oncol. 1994;  20(5) 313-316
    PubMedGoogle Scholar
  • 64 Aupetit J F, Ritz B, Ferrini M, Coppin M, Champsaur G. Images in cardiovascular medicine. Hydatid cyst of the interventricular septum.  Circulation. 1997;  95(9) 2325-2326
    PubMedGoogle Scholar
  • 65 Salomon J L, Bourgeois A, Le Baleur A, Pillot P, Gillot C, Frileux C. [Product of choice for maintenance sclerosis: 66% glucose solution].  Phlebologie. 1983;  36(3) 249-254
    PubMedGoogle Scholar
  • 66 Consolo P, Luigiano C, Giacobbe G, Scaffidi M G, Pellicano R, Familiari L. Cyanoacrylate glue in the management of gastric varices.  Minerva Med. 2009;  100(1) 115-121
    PubMedGoogle Scholar
  • 67 Kiyosue H, Mori H, Matsumoto S, Yamada Y, Hori Y, Okino Y. Transcatheter obliteration of gastric varices. Part 1. Anatomic classification.  Radiographics. 2003;  23(4) 911-920
    CrossrefPubMedGoogle Scholar
  • 68 Baysal T, Soylu A. Percutaneous treatment of simple renal cysts with n-butyl cyanoacrylate and iodized oil.  Diagn Interv Radiol. 2009;  15(2) 148-152
    PubMedGoogle Scholar
  • 69 Kim S H, Moon M W, Lee H J, Sim J S, Kim S H, Ahn C. Renal cyst ablation with n-butyl cyanoacrylate and iodized oil in symptomatic patients with autosomal dominant polycystic kidney disease: preliminary report.  Radiology. 2003;  226(2) 573-576
    CrossrefPubMedGoogle Scholar
  • 70 Cragg A H, Galliani C A, Rysavy J A, Castaneda-Zuniga W R, Amplatz K. Endovascular diathermic vessel occlusion.  Radiology. 1982;  144(2) 303-308
    PubMedGoogle Scholar
  • 71 Herrera M A, Di Segni R, Kaye K W et al.. Embolization of the internal spermatic vein with mechanical devices for the treatment of varicocele. In Castaneda-Zuniga WR, Tadavarthy SM Interventional Radiology. Baltimore; Williams and Wilkins 1992: 100-110
    Google Scholar
  • 72 VenBrux AC .Pelvic venous incompetence: pelvic congestion syndrome. In: Baum S, Pentecost MJ Abrams' Angiography Interventional Radiology. 2nd ed. Philadelphia; Lippincott Williams and Wilkins 2006: 830-836
    Google Scholar
  • 73 Wible B C, Mitchell S. Doxycycline sclerotherapy of an intraosseous femoral lymphatic malformation: case report and literature review.  J Vasc Interv Radiol. 2009;  20(5) 660-663
    CrossrefPubMedGoogle Scholar

Kimi L KondoD.O. 

Assistant Professor, Department of Radiology, University of Colorado Denver School of Medicine, Mail Stop L954

12401 East 17th Avenue, Room 537, Aurora, CO 80045

Email: Kimi.Kondo@ucdenver.edu

      >